Research
Industry Research

Home / Public affairs / Research / Industry Research
News > News Article

August 2019

Growth and confidence hit in Q2 – output expected to recover in Q3

Growth and confidence hit in Q2 – output expected to recover in Q3

GROWTH AND CONFIDENCE HIT IN Q2 – OUTPUT EXPECTED TO RECOVER IN Q3 BUT RESTORING CONFIDENCE WILL TAKE LONGER

The UK printing industry was not immune to the economic turmoil in the second quarter of 2019 - both output and orders suffered a contraction to duck below the forecasts and into negative territory. Orders are expected to remain subdued in Q3 but output is expected to bounce back.

The latest Printing Outlook survey shows 32% of printers increased output levels in the second quarter of 2019. The remaining respondents were split evenly; 34% held output steady and 34% experienced a decline in output.

The resulting balance (the difference between the ups and the downs) was -2, a continuation of the decline experiences in Q1 that followed the Q4 seasonal boost. This was an underperformance in comparison to the forecast for Q2 (the forecasted balance was +8).

Downloads
BPIF Press Release – Printing Outlook Q3 - Size: 478Kb Download
Share this page
Most Read

Intergraf Economic News (Paper Prices) - March 2024Intergraf Economic News (Paper Prices) - March 2024

March 2024

Access the latest edition of the Economic Newsletter for the European Printing Industry for data on paper consumption, and pricing data for pulp, paper and recovered paper. Data for packaging papers and board is also available with this edition.

STUDY EXPOSES HIGH COST OF PHARMACIES PRINTING MEDICAL INFORMATION LEAFLETSSTUDY EXPOSES HIGH COST OF PHARMACIES PRINTING MEDICAL INFORMATION LEAFLETS

March 2024

Intergraf welcomes the release of a study by our partner MLPS (Medical Leaflet = Patient Safety), a subgroup of the European Carton Manufacturers Association (ECMA) shedding light on the potential economic costs associated with the proposed use of Print on Demand (PoD) leaflets in the pharmaceutical legislation revision.

For more information please contact:
Kyle Jardine
Kyle Jardine
0289 002 0135